Medline Inc. (MDLN) stock

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026Score 5/3021% above fair value

$32.12+0.12 (+0.37%)

Close on Oct 30, 2026Market cap $42.23BP/E –Yield –

Earnings

Medline's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

–

Not yet scheduled

Revenue, Q2 FY2026

$7.70B

Adjusted Diluted EPS, Q2 FY2026

$0.50

Latest guidance

Raised

Aug 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Medline's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q2 FY2026ended Jun 27, 2026	Aug 5, 2026before the open	$7.70B	–	$0.07	$0.50	Release
Q1 FY2026ended Mar 28, 2026	May 6, 2026before the open	$7.40B	–	$0.16	$0.33	Release
Q4 FY2025ended Dec 31, 2025	Feb 25, 2026before the open	$7.80B	–	-$0.01	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Medline's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Organic Salesnon-GAAP	FY2026	+9% – +10%	+8.5% – +9.5%	Raised	Aug 5, 2026
Adjusted EBITDAnon-GAAP	FY2026	$3.30B – $3.40B	$3.50B – $3.60B	Lowered	Aug 5, 2026

Guidance history

Every forecast Medline put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 5, 2026	Adjusted EBITDA	FY2026	$3.30B – $3.40B	Lowered
Aug 5, 2026	Organic Sales	FY2026	+9% – +10%	Raised
May 6, 2026	Adjusted EBITDA	FY2026	$3.50B – $3.60B	Reaffirmed
May 6, 2026	Organic Sales growth	FY2026	+8.5% – +9.5%	Raised
Feb 25, 2026	Adjusted EBITDA	FY2026	$3.50B – $3.60B	New
Feb 25, 2026	Organic Sales	FY2026	+8% – +9%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.